One-bag protocol for cancer drug hypersensitivity
The 1BP RDD protocols demonstrate consistent safety and completion rates. Our findings suggest that patient safety relies on the precise control of exposure kinetics rather than multiple dilution steps. By reducing procedural complexity and duration, 1BP provides a robust strategy to streamline workflows, optimize resource allocation, and enhance patient access to cancer therapies across diverse health care settings. INTERNATIONAL PROSPECTIVE REGISTER OF SYSTEMATIC REVIEWS (PROSPERO) REGISTRATION: CRD42024586580.
Authors
- Carlos Macouzet-Sánchez (ORCID: https://orcid.org/0000-0002-5948-6784)
- Cindy Elizabeth de Lira-Quezada (ORCID: https://orcid.org/0000-0002-6692-8130)
- Natalhie Acuña Ortega (ORCID: https://orcid.org/0000-0002-4190-5389)
- Alejandra Macías-Weinmann (ORCID: https://orcid.org/0000-0003-4007-2255)
- Ignacio Javier Ansotegui (ORCID: https://orcid.org/0000-0002-6942-1511)
- Sandra Nora González Díaz (ORCID: https://orcid.org/0000-0002-3612-0042)
- Andrés Noyola‐Perez (ORCID: https://orcid.org/0000-0003-2713-2663)
- Valeria Muñoz-Silva
- Rosa Ivett Guzman-Avilan (ORCID: https://orcid.org/0000-0002-9850-9360)
- Mário Morais‐Almeida
- Jesus Marcelo Alanis-Alvarez
Institutions
- Universidad Autónoma de Nuevo León (MX)
- CUF Porto Hospital (PT)
- Hospital Quirónsalud Barcelona (ES)
- Hospital Universitario Dr José Eleuterio Gonzalez (MX)
- Hospital do Desterro (PT)
Publication Details
- Journal
- Annals of Allergy Asthma & Immunology
- Published
- 2025-07-05
- DOI
- https://doi.org/10.1016/j.anai.2025.06.034
- Citations
- 3
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 4.18